Home › Health › FDA Gets Rousing Media Attention Regarding Narcotic Pain Drugs. Will It Make An Impact On The Patients?

FDA Gets Rousing Media Attention Regarding Narcotic Pain Drugs. Will It Make An Impact On The Patients?

By rkutchjm on September 17, 2013 • ( 0 )

There have been significant increases in mortality with regard to sustained release pain drugs. In 2010, almost 17,000 deaths attributed to the category of a narcotic painkiller called OxyContin. Other familiar names in the group are Avinza, Kadian, MS Contin, etc. Many are purchased legally through pharmacies and then diverted illegally for significant profit.

For a quick high, users chew, snort, crush and even inject these preparations. This triggers high amounts of dopamine to be released in the brain. The chemical gives that pleasurable euphoria. Addicts require higher and higher amounts to get the same effect. Continuation will lead to excessive respiratory depression. As a result, the victim is found rigid, cold and dead.

Renovating Your Mind says “Our FDA just puffed up its chest when it comes to new warnings on pain medications.” New guidelines state that sustained-release narcotic preparations must be used for only severe not moderate pain as a last resort. Unfortunately, there is no incentive to follow these new standards of treatment. Who is actually going to heed these words? Do warnings on cigarette boxes prevent anyone from smoking?

Are the illegal dealers going to stop selling the drugs? Are the buyers going to stop making their purchases? Users, addicted because of a valid pain issue, are they going to go off the medications? Will doctors stop prescribing them for moderate pain if the patient claims the pain is severe?

This will change nothing in regard to unfortunate drug overdoses. FDA is covering its own ass because the problem is accelerating rapidly throughout the United States. Take the focus off of cannabis and magnify efforts on narcotic and controlled pain medications. Politicians and law enforcement reset your sights onto target killers such as prescription narcotics, heroin, cocaine, designer drugs, etc.